Test Price
210 AED✅ Home Collection Available
Measles (Rubeola) Antibody IgM Test in UAE – 210 AED – DHA Licensed
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity via Chemiluminescent Immunoassay (CLIA) in an ISO 9001:2015 accredited facility (Cert: INT/EGQ/2509DA/3139).
- Specimen Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection operates daily from 8 AM to 11 PM across Dubai, Abu Dhabi, and Sharjah.
- Clinical Backing: Post-result telephonic guidance by a DHA-licensed General Practitioner ensures informed interpretation and next-step planning.
- Insurance Facilitation: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Measles (Rubeola) Antibody IgM test is a serological assay that identifies acute-phase IgM antibodies using Chemiluminescent Immunoassay (CLIA). This method confirms a recent or ongoing measles infection with results available the same day, enabling rapid clinical decision-making. CLIA technology provides superior sensitivity and specificity compared to traditional enzyme-linked methods, reducing false-positive cross-reactivity from other viral pathogens.
| Parameter | DNA Labs UAE – CLIA | Conventional ELISA |
|---|---|---|
| Diagnostic Sensitivity | 99.9% | ~93–95% |
| Assay Principle | Chemiluminescent Immunoassay (CLIA) | Enzyme-Linked Immunosorbent Assay |
| Reporting Time | Same day (within hours of sample receipt) | 1–3 business days |
| Sample Volume & Handling | 2 mL serum (minimum 1 mL); refrigerated or frozen transport required | Similar volume; longer ambient stability but lower throughput |
Physician Insight & Safety Protocols
Interpretation of measles IgM serology must integrate vaccination history, clinical presentation, and epidemiological exposure risk. A positive IgM result indicates recent infection, but false negatives can occur in the first three days of rash onset, and false positives may arise from parvovirus B19 or rubella cross-reactivity. Patients should never modify treatment without direct consultation with a qualified clinician.
— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132
Exclusion Criteria & Emergency Red Flags
- Exclusion: Immunocompromised individuals may show delayed or absent IgM production; infants under six months may retain maternal IgG alone, masking acute serology.
- Urgent Referral Indicators: Temperature exceeding 39.5°C, altered consciousness, respiratory distress, photophobia with nuchal rigidity, or seizure-like activity mandate immediate emergency evaluation.
- Pre-analytical Stewardship: Hemolyzed, icteric, or lipemic sera can interfere with CLIA signal detection; repeat collection may be necessary if sample quality is compromised.
Patient FAQ & Clinical Guidance
1. What does a positive Measles IgM result indicate?
A positive IgM antibody test points to a recent or acute measles infection. Your physician will correlate this with your vaccination record, symptoms, and any known exposure to confirm the diagnosis and initiate appropriate public health measures.
2. How reliable is this test compared to other methods?
Our CLIA-based assay delivers 99.9% diagnostic sensitivity and minimal cross-reactivity, making it the preferred serological method for detecting acute measles infection. It outperforms standard ELISA in both speed and accuracy.
3. Do I need to fast or prepare in any way before the blood draw?
No special preparation is required. You may eat and drink normally before your appointment. The sample can be collected at any time of day, and our mobile phlebotomy service accommodates your schedule.
4. What happens after I receive my results?
A DHA-licensed physician will contact you by telephone to explain the findings and provide clinical guidance. If your result is positive, you will be advised on isolation protocols, contact tracing, and follow-up care.
5. Can this test be performed on a child or infant?
Yes, the test is suitable for paediatric patients. For infants under six months, results should be interpreted cautiously because maternal antibodies may still be present. A smaller blood volume can be collected for younger children.
UAE Regulatory & Data Privacy Adherence
Legal & Compliance Framework
DNA Labs UAE operates under DHA Facility License Number 1143 and complies with all applicable UAE federal laws:
- Data Protection: Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) governs all patient information handling, storage, and sharing.
- Health Information Management: Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields regulates electronic health data systems.
- Medical Liability & Patient Safety: Federal Decree-Law No. 4 of 2016 on Medical Liability ensures clinical accountability and patient consent protocols.
Clinical & Logistical Metadata
| Test Name | Measles (Rubeola) Antibody IgM – Serology |
| Price (AED) | 210 |
| Turnaround Time | Same day (results within hours of sample receipt) |
| Sample Type / Matrix | Serum (2 mL in SST; minimum 1 mL) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM |
| Methodology Used | Chemiluminescent Immunoassay (CLIA) |
| ICD-10-CM Code | B05.9 (Measles without complication) |
| LOINC Code | 6474-2 (Measles virus IgM Ab [Presence] in Serum) |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians